1. R-91154
1. Prosynap
2. 144665-07-6
3. R-87926
4. Chembl281724
5. V2sib71583
6. (2s)-1-[4-[1,3-benzothiazol-2-yl(methyl)amino]piperidin-1-yl]-3-(3,4-difluorophenoxy)propan-2-ol
7. (s)-1-(4-(benzo[d]thiazol-2-yl(methyl)amino)piperidin-1-yl)-3-(3,4-difluorophenoxy)propan-2-ol
8. Lubeluzole [inn]
9. Lubeluzol
10. Lubeluzole [usan:inn:ban]
11. Unii-v2sib71583
12. Prosynap (tn)
13. R 87926
14. Lubeluzole [mi]
15. Lubeluzole Dihydrochloride
16. Lubeluzole (usan/inn)
17. Lubeluzole [usan]
18. Lubeluzole [mart.]
19. Lubeluzole [who-dd]
20. Schembl159725
21. Dtxsid60162779
22. Chebi:135703
23. Bdbm50066066
24. Jk-8792
25. Ncgc00487398-02
26. (+)-(s)-4-(2-benzothiazolylmethylamino)-alpha-((3,4-difluorophenoxy)methyl)-1-piperidineethanol
27. 1-piperidineethanol, 4-(2-benzothiazolylmethylamino)-alpha-((3,4-difluorophenoxy)methyl)-, (s)-
28. Hy-105084
29. Cs-0024938
30. D04789
31. Q6695177
32. (+)-(s)-4-(2-benzothiazolylmethylamino)-.alpha.-((3,4-difluorophenoxy)methyl)-1-piperidineethanol
33. (2s)-1-[4-(1,3-benzothiazol-2-yl-methylamino)piperidin-1-yl]-3-(3,4-difluorophenoxy)propan-2-ol
34. (s)-1-[4-(benzothiazol-2-yl-methyl-amino)-piperidin-1-yl]-3-(3,4-difluoro-phenoxy)-propan-2-ol
35. 1-[4-(benzothiazol-2-yl-methyl-amino)-piperidin-1-yl]-3-(3,4-difluoro-phenoxy)-propan-2-ol(lubeluzole)
36. 1-piperidineethanol, 4-(2-benzothiazolylmethylamino)-.alpha.-((3,4-difluorophenoxy)methyl)-, (s)-
Molecular Weight | 433.5 g/mol |
---|---|
Molecular Formula | C22H25F2N3O2S |
XLogP3 | 4.7 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 8 |
Rotatable Bond Count | 7 |
Exact Mass | 433.16355455 g/mol |
Monoisotopic Mass | 433.16355455 g/mol |
Topological Polar Surface Area | 77.1 Ų |
Heavy Atom Count | 30 |
Formal Charge | 0 |
Complexity | 541 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 1 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Cardiovascular Agents
Agents that affect the rate or intensity of cardiac contraction, blood vessel diameter, or blood volume. (See all compounds classified as Cardiovascular Agents.)
Neuroprotective Agents
Drugs intended to prevent damage to the brain or spinal cord from ischemia, stroke, convulsions, or trauma. Some must be administered before the event, but others may be effective for some time after. They act by a variety of mechanisms, but often directly or indirectly minimize the damage produced by endogenous excitatory amino acids. (See all compounds classified as Neuroprotective Agents.)
LOOKING FOR A SUPPLIER?